114 related articles for article (PubMed ID: 9096424)
1. Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C.
Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A
Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):245-9. PubMed ID: 9096424
[TBL] [Abstract][Full Text] [Related]
2. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.
Ampurdanés S; Olmedo E; Maluenda MD; Forns X; López-Labrador FX; Costa J; Sánchez-Tapias JM; de Anta MT; Rodés J
J Hepatol; 1996 Dec; 25(6):827-32. PubMed ID: 9007709
[TBL] [Abstract][Full Text] [Related]
3. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
Brouwer JT; Nevens F; Kleter B; Elewaut A; Adler M; Brenard R; Chamuleau RA; Michielsen PP; Pirotte J; Hautekeete ML; Weber J; Bourgeois N; Hansen BE; Bronkhorst CM; ten Kate FJ; Heijtink RA; Fevery J; Schalm SW
J Hepatol; 1998 Jun; 28(6):951-9. PubMed ID: 9672169
[TBL] [Abstract][Full Text] [Related]
5. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
Kondo M; Tanaka K; Ikeda M; Arata S; Saito S; Sakaguchi T; Morimoto M; Fujii T; Mitsui K; Okazaki H; Hoshino M; Sekihara H
J Gastroenterol Hepatol; 1996 Mar; 11(3):236-40. PubMed ID: 8742919
[TBL] [Abstract][Full Text] [Related]
6. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
Orito E; Mizokami M; Suzuki K; Ohba K; Ohno T; Mori M; Hayashi K; Kato K; Iino S; Lau JY
J Med Virol; 1995 Jun; 46(2):109-15. PubMed ID: 7636496
[TBL] [Abstract][Full Text] [Related]
7. Early negative tests for serum HCV RNA as a predictor of sustained response to interferon therapy in patients with chronic hepatitis C.
Marcellin P; Martinot M; Erlinger S
Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):237-8. PubMed ID: 9096422
[TBL] [Abstract][Full Text] [Related]
8. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
[TBL] [Abstract][Full Text] [Related]
10. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C.
Kakumu S; Aiyama T; Okumura A; Iwata K; Ishikawa T; Yoshioka K
J Gastroenterol Hepatol; 1997 Jun; 12(6):468-72. PubMed ID: 9195406
[TBL] [Abstract][Full Text] [Related]
11. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
12. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
[TBL] [Abstract][Full Text] [Related]
13. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
14. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC
Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
Shindo M; Arai K; Sokawa Y; Okuno T
Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.
Yun ZB; Reichard O; Chen M; Lundeberg J; Norkrans G; Fryden A; Sönnerborg A; Weiland O
Scand J Infect Dis; 1994; 26(3):263-70. PubMed ID: 7939425
[TBL] [Abstract][Full Text] [Related]
20. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
